Lee J , Dunphy WG .

GM043974 NIGMS NIH HHS , GM070891 NIGMS NIH HHS , R01 GM043974 NIGMS NIH HHS , R01 GM070891 NIGMS NIH HHS , R37 GM043974 NIGMS NIH HHS

	FIGURE 1:. The MRN complex is involved in the pathway that activates Chk1 in response to DNA replication blockages in Xenopus egg extracts. (A) Interphase egg extracts were subjected to an immunodepletion procedure with beads containing control antibodies (lane 1) or anti-Nbs1 antibodies (lanes 2 and 3). rMRN, prepared as described in (C), was added back to a level close to the endogenous amount (lane 3). Samples were immunoblotted for Nbs1. (B) Egg extracts from (A) were incubated with sperm chromatin and [35S]Chk1 in the absence (lane 1) or presence (lanes 2–4) of APH. Nuclear fractions from the extracts were processed for SDS–PAGE and phosphorimaging to assess phosphorylation of Chk1. Unshifted Chk1 was marked with a bar and slower-migrating band(s) with an arrow. Phosphorylation was expressed as a percentage of the level in mock-depleted extracts (lane 2). Results (mean ± SD) are from three independent experiments. (C) Expression and purification of rMRN from insect cells. Sf9 insect cells were coinfected with recombinant baculoviruses encoding human Mre11 (hMre11-His6), human Rad50 (hRad50-His6), and Xenopus Nbs1 (xNbs1-FLAG). Cell lysates were incubated with nickel (Ni) agarose, and bound proteins were eluted with imidazole buffer (lane 2). Next, this eluate was incubated with anti-FLAG antibody beads to achieve further purification. The flow-through fraction (FT) from this step is shown in lane 4. Finally, the bead-bound proteins were eluted with FLAG peptide (lane 3). Lane 1 contains molecular size markers. Samples were separated by SDS–PAGE and stained with Coomassie Brilliant Blue. (D) Egg extracts from (A) were incubated in the absence (lane 1) or presence (lanes 2–4) of pA-pT. [35S]-labeled Chk1 protein was included in extracts in order to monitor checkpoint activation. Samples were analyzed by SDS–PAGE and phosphorimaging. (E) Samples prepared as in (B) were analyzed for the phosphorylation status of various endogenous proteins by immunoblotting with antibodies that detect Ser-344 of Chk1, Ser-864 of Claspin, and Ser-92 of Mcm2. Samples were also immunoblotted for the corresponding protein antigens.
	FIGURE 2:. The MRN complex associates with chromatin in a replication-dependent manner. (A) Time course for binding of Nbs1 to chromatin. Interphase egg extracts treated with control buffer (top), APH (middle), or PflMI (bottom) were incubated with sperm chromatin (lanes 2–8). Chromatin fractions were prepared at the indicated times for immunoblotting with anti-Nbs1 and anti-Orc2 antibodies. Lane 1 depicts 1 μl of egg extract. (B) Extracts incubated with no checkpoint inducer (lanes 2, 5, and 8), APH (A; lanes 3, 6, and 9), or PflMI (P; lanes 4, 7, and 10) were treated with control buffer (lanes 2–4), Geminin (lanes 5–7), or p27 (lanes 8–10). Chromatin fractions were prepared and immunoblotted for Nbs1 (top) and PCNA (bottom). The sample for lane 1 lacked any added sperm chromatin. (C) Chromatin fractions were prepared from mock-treated (lanes 1 and 2) or Cdc45-depleted (lanes 3 and 4) extracts that had been incubated in the absence (lane 1) or presence (lanes 2–4) of APH. Recombinant Xenopus Cdc45 (r45) was added back in lane 4 (arrow). Samples were immunoblotted for the indicated proteins. (D) Chromatin fractions were prepared from mock-treated (lanes 1 and 2) or RPA-depleted (lanes 3 and 4) extracts that had been incubated in the absence (lane 1) or presence (lanes 2–4) of APH. Recombinant human RPA (rRPA) was added to the extract in lane 4. Samples were immunoblotted with antibodies against Xenopus Nbs1 and RPA70. Note that human RPA70 does not cross-react with the anti-Xenopus antibodies. (E) Chromatin fractions were prepared from mock-treated (lanes 1–3) or TopBP1-depleted (lanes 4–5) extracts that had been incubated in the absence (lane 1) or presence of either APH (A; lanes 2 and 4) or PflMI (P; lanes 3 and 5). Fractions were immunoblotted for the indicated proteins.
	FIGURE 3:. MRN and Rad17 regulate activation of Chk1 in an additive manner. (A) Mock-treated (lanes 1 and 2) or Nbs1-depleted (lanes 3 and 4) extracts were incubated in the absence (lane 1) or presence (lanes 2–4) of APH. Recombinant MRN was added back to the incubation shown in lane 4. Chromatin fractions were prepared and immunoblotted for the indicated proteins. (B) Quantitation of binding of proteins to chromatin in mock-treated extracts incubated in the absence (1) or presence (2) of APH and in Nbs1-depleted extracts incubated in the presence of APH (3). Values, compiled from two independent experiments, are expressed relative to mock-treated, APH-containing extracts. (C) Egg extracts were subjected to an immunodepletion procedure with control antibodies (lane 1), anti-Rad17 antibodies (lane 2), anti-Nbs1 antibodies (lane 3), or both anti-Rad17 and anti-Nbs1 antibodies (lane 4). Extracts were immunoblotted for the indicated proteins. (D) Extracts from (C) were incubated in the absence (lane 1) or presence (lanes 2–5) of APH. Chromatin fractions were immunoblotted for the indicated proteins. (E) Extracts from (C) were incubated with [35S]Chk1 in the absence (lane 1) or presence (lanes 2–5) of APH. Nuclear fractions from the extracts were processed for phosphorimaging to detect [35S]Chk1 (second panel from top) or for immunoblotting with antibodies that detect pSer-344 of Chk1, pSer-864 of Claspin, Claspin, pSer-1131 of TopBP1, and TopBP1, as indicated in the remaining panels.
	FIGURE 4:. The Nbs1 component of the MRN complex is dispensable for the APH-induced activation of Chk1. (A) Domains of the Xenopus Nbs1 protein. The protein contains an FHA domain and two BRCT domains in its N-terminal region and an Mre11-binding domain (MB) and ATM-binding domain (AB) in its C-terminal region. Two deletion constructs of Nbs1 (∆1 and ∆2) are depicted. (B and D) Egg extracts were mock-treated with control antibodies (lane 1) or immunodepleted with anti-Nbs1 antibodies (lanes 2–4). Extracts were supplemented with control buffer (B and D, lanes 1 and 2), wild-type rMRN complex (B and D, lane 3), mutant rMRN∆1 complex (B, lane 4), or mutant rMRN∆2 complex (D, lane 4). Extracts were immunoblotted with anti-Nbs1 and anti-TopBP1 antibodies. (C and E) Extracts from (B) and (D), respectively, were incubated with [35S]Chk1 in the absence (lane 1) or presence (lanes 2–5) of APH. Nuclear fractions from the extracts were processed for phosphorimaging to assess phosphorylation-dependent shifting of Chk1. Numbers above each lane denote quantitation of phosphorylation relative to mock-depleted, APH-treated extracts. (F) Mock-treated (lane 1) or Nbs1-depleted extracts (lanes 2–4) were supplemented with control buffer (lanes 1 and 2), wild-type rMRN complex (lane 3), or recombinant MR complex lacking Nbs1 (lane 4). For these experiments, the Rad50 subunit in the trimeric MRN and dimeric MR complexes contained a C-terminal FLAG tag (see Materials and Methods). Extracts were immunoblotted for the indicated proteins. (G) Extracts in (F) were incubated with [35S]Chk1 in the absence (lane 1) or presence (lanes 2–5) of APH. Nuclear fractions from the extracts were processed for phosphorimaging.
	FIGURE 5:. Mre11 is essential for the DNA replication checkpoint in egg extracts. (A) Mock-depleted (lanes 1 and 2) or Nbs1-depleted (lanes 3–7) extracts were supplemented with the following: control buffer (lanes 1–3), recombinant MRN complexes containing all wild-type subunits (lane 4), a Rad50-SR mutant subunit (lane 5), or an Mre11-3 mutant subunit (lane 6), and dimeric MR complex (lane 7). Extracts were incubated with [35S]Chk1 in the absence (lane 1) or presence (lanes 2–7) of APH. Nuclear fractions from the extracts were processed for immunoblotting with anti–pSer-344 Chk1 antibodies (top) or for phosphorimaging to detect radiolabeled Chk1 (bottom). Numbers above each lane denote quantitation of phosphorylation relative to mock-depleted, APH-treated extracts. (B) Mock-treated (lane 1) or Nbs1-depleted extracts (lanes 2–4) were supplemented with control buffer (lanes 1 and 2), recombinant Mre11-Nbs1 complex (MN, lane 3) or recombinant Mre11 protein (lane 4). Extracts were immunoblotted for the indicated proteins. (C) Extracts from (B) were incubated with [35S]Chk1 in the absence (lane 1) or presence (lanes 2–5) of APH. Nuclear fractions from the extracts were processed for immunoblotting with anti–pSer-344 Chk1 antibodies (top) or for phosphorimaging to detect radiolabeled Chk1 (bottom). (D) Mock-treated (lane 1) or Nbs1-depleted (lanes 2–4) extracts were supplemented with control buffer (lanes 1 and 2), recombinant wild-type Mre11 protein (lane 3), or the mutant Mre11-3 protein (lane 4). Extracts were immunoblotted for the indicated proteins. (E) Extracts from (D) were incubated with [35S]Chk1 in the absence (lane 1) or presence (lanes 2–5) of APH. Nuclear fractions from the extracts were processed for immunoblotting with anti–pSer-344 Chk1 antibodies (top) or for phosphorimaging to detect radiolabeled Chk1 (bottom). (F) Effects of mirin on the DNA replication checkpoint. Egg extracts were preincubated for 20 min in the absence (lanes 1 and 2) or presence (lanes 3 and 4) of 0.8 mM mirin. At this point, extracts were supplemented with sperm chromatin and [35S]Chk1 and incubated in the absence (lanes 1 and 3) or presence (lanes 2 and 4) of APH. Nuclear fractions (top four panels) were prepared and processed for phosphorimaging and immunoblotting with the indicated antibodies. Numbers above the lanes containing Chk1 denote phosphorylation relative to APH-containing extracts treated with DMSO. Chromatin fractions (bottom three panels) were prepared and immunoblotted for TopBP1, Mre11, and Orc2. The numbers above the lanes containing TopBP1 represent the binding of TopBP1 to chromatin relative to APH-containing extracts treated with DMSO.

Arthur, Structural and functional analysis of Mre11-3. 2004, Pubmed

Arthur, Structural and functional analysis of Mre11-3. 2004, Pubmed
Bhaskara, Rad50 adenylate kinase activity regulates DNA tethering by Mre11/Rad50 complexes. 2007, Pubmed , Xenbase
Buis, Mre11 nuclease activity has essential roles in DNA repair and genomic stability distinct from ATM activation. 2008, Pubmed
Byun, Functional uncoupling of MCM helicase and DNA polymerase activities activates the ATR-dependent checkpoint. 2005, Pubmed , Xenbase
Ciccia, The DNA damage response: making it safe to play with knives. 2010, Pubmed
Cimprich, ATR: an essential regulator of genome integrity. 2008, Pubmed
Coleman, The Xenopus Cdc6 protein is essential for the initiation of a single round of DNA replication in cell-free extracts. 1996, Pubmed , Xenbase
Cortez, ATR and ATRIP: partners in checkpoint signaling. 2001, Pubmed
Costanzo, Mre11 protein complex prevents double-strand break accumulation during chromosomal DNA replication. 2001, Pubmed , Xenbase
Cuadrado, ATM regulates ATR chromatin loading in response to DNA double-strand breaks. 2006, Pubmed
Dasso, Completion of DNA replication is monitored by a feedback system that controls the initiation of mitosis in vitro: studies in Xenopus. 1990, Pubmed , Xenbase
Delacroix, The Rad9-Hus1-Rad1 (9-1-1) clamp activates checkpoint signaling via TopBP1. 2007, Pubmed
Dupré, A forward chemical genetic screen reveals an inhibitor of the Mre11-Rad50-Nbs1 complex. 2008, Pubmed , Xenbase
Ellison, Biochemical characterization of DNA damage checkpoint complexes: clamp loader and clamp complexes with specificity for 5' recessed DNA. 2003, Pubmed
Ge, Chk1 inhibits replication factory activation but allows dormant origin firing in existing factories. 2010, Pubmed
Guo, Requirement for Atr in phosphorylation of Chk1 and cell cycle regulation in response to DNA replication blocks and UV-damaged DNA in Xenopus egg extracts. 2000, Pubmed , Xenbase
Hashimoto, The phosphorylated C-terminal domain of Xenopus Cut5 directly mediates ATR-dependent activation of Chk1. 2006, Pubmed , Xenbase
Hashimoto, RAD51- and MRE11-dependent reassembly of uncoupled CMG helicase complex at collapsed replication forks. 2011, Pubmed , Xenbase
Hashimoto, Rad51 protects nascent DNA from Mre11-dependent degradation and promotes continuous DNA synthesis. 2010, Pubmed , Xenbase
Hashimoto, Xenopus Cut5 is essential for a CDK-dependent process in the initiation of DNA replication. 2003, Pubmed , Xenbase
Hekmat-Nejad, Xenopus ATR is a replication-dependent chromatin-binding protein required for the DNA replication checkpoint. , Pubmed , Xenbase
Hickson, Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. 2004, Pubmed
Jazayeri, ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks. 2006, Pubmed
Jones, XRad17 is required for the activation of XChk1 but not XCds1 during checkpoint signaling in Xenopus. 2003, Pubmed , Xenbase
Kanaar, DNA repair by the MRN complex: break it to make it. 2008, Pubmed
Kumagai, TopBP1 activates the ATR-ATRIP complex. 2006, Pubmed , Xenbase
Kumagai, The Xenopus Chk1 protein kinase mediates a caffeine-sensitive pathway of checkpoint control in cell-free extracts. 1998, Pubmed , Xenbase
Kumagai, Claspin, a novel protein required for the activation of Chk1 during a DNA replication checkpoint response in Xenopus egg extracts. 2000, Pubmed , Xenbase
Kumagai, Claspin and the activated form of ATR-ATRIP collaborate in the activation of Chk1. 2004, Pubmed , Xenbase
Kumagai, Repeated phosphopeptide motifs in Claspin mediate the regulated binding of Chk1. 2003, Pubmed , Xenbase
Labib, How do Cdc7 and cyclin-dependent kinases trigger the initiation of chromosome replication in eukaryotic cells? 2010, Pubmed
Lee, Rad17 plays a central role in establishment of the interaction between TopBP1 and the Rad9-Hus1-Rad1 complex at stalled replication forks. 2010, Pubmed , Xenbase
Lee, Activation and regulation of ATM kinase activity in response to DNA double-strand breaks. 2007, Pubmed
Lee, The Rad9-Hus1-Rad1 checkpoint clamp regulates interaction of TopBP1 with ATR. 2007, Pubmed , Xenbase
Lee, Purification and biochemical characterization of ataxia-telangiectasia mutated and Mre11/Rad50/Nbs1. 2006, Pubmed
Lee, Claspin, a Chk1-regulatory protein, monitors DNA replication on chromatin independently of RPA, ATR, and Rad17. 2003, Pubmed , Xenbase
Li, Absence of BLM leads to accumulation of chromosomal DNA breaks during both unperturbed and disrupted S phases. 2004, Pubmed , Xenbase
Liu, Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. 2000, Pubmed
McGarry, Geminin, an inhibitor of DNA replication, is degraded during mitosis. 1998, Pubmed , Xenbase
Meng, Role for casein kinase 1 in the phosphorylation of Claspin on critical residues necessary for the activation of Chk1. 2011, Pubmed
Mimura, Xenopus Cdc45-dependent loading of DNA polymerase alpha onto chromatin under the control of S-phase Cdk. 1998, Pubmed , Xenbase
Mirzoeva, DNA replication-dependent nuclear dynamics of the Mre11 complex. 2003, Pubmed
Moncalian, The rad50 signature motif: essential to ATP binding and biological function. 2004, Pubmed
Mordes, TopBP1 activates ATR through ATRIP and a PIKK regulatory domain. 2008, Pubmed
Morgan, Cyclin-dependent kinases: engines, clocks, and microprocessors. 1997, Pubmed
Murray, Cell cycle extracts. 1991, Pubmed
Myers, Rapid activation of ATR by ionizing radiation requires ATM and Mre11. 2006, Pubmed
Méndez, Perpetuating the double helix: molecular machines at eukaryotic DNA replication origins. 2003, Pubmed , Xenbase
Nam, ATR signalling: more than meeting at the fork. 2011, Pubmed
Olson, The Mre11-Rad50-Nbs1 complex acts both upstream and downstream of ataxia telangiectasia mutated and Rad3-related protein (ATR) to regulate the S-phase checkpoint following UV treatment. 2007, Pubmed
Parrilla-Castellar, Dial 9-1-1 for DNA damage: the Rad9-Hus1-Rad1 (9-1-1) clamp complex. 2004, Pubmed
Perry, Cdc25 and Wee1: analogous opposites? 2007, Pubmed
Petermann, Evidence that the ATR/Chk1 pathway maintains normal replication fork progression during unperturbed S phase. 2006, Pubmed
Robison, Replication protein A and the Mre11.Rad50.Nbs1 complex co-localize and interact at sites of stalled replication forks. 2004, Pubmed
Sancar, Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. 2004, Pubmed
Sclafani, Cell cycle regulation of DNA replication. 2007, Pubmed
Shiloh, The ATM-mediated DNA-damage response: taking shape. 2006, Pubmed , Xenbase
Stewart, The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder. 1999, Pubmed
Stiff, Nbs1 is required for ATR-dependent phosphorylation events. 2005, Pubmed
Stracker, The MRE11 complex: starting from the ends. 2011, Pubmed
Stracker, The Mre11 complex and the metabolism of chromosome breaks: the importance of communicating and holding things together. 2004, Pubmed
Symington, Double-strand break end resection and repair pathway choice. 2011, Pubmed
Tittel-Elmer, The MRX complex stabilizes the replisome independently of the S phase checkpoint during replication stress. 2009, Pubmed
Van, Continued primer synthesis at stalled replication forks contributes to checkpoint activation. 2010, Pubmed , Xenbase
Van Hatten, The Xenopus Xmus101 protein is required for the recruitment of Cdc45 to origins of DNA replication. 2002, Pubmed , Xenbase
Walter, Initiation of eukaryotic DNA replication: origin unwinding and sequential chromatin association of Cdc45, RPA, and DNA polymerase alpha. 2000, Pubmed , Xenbase
Williams, Mre11-Rad50-Nbs1 conformations and the control of sensing, signaling, and effector responses at DNA double-strand breaks. 2010, Pubmed
Yoo, Ataxia-telangiectasia mutated (ATM)-dependent activation of ATR occurs through phosphorylation of TopBP1 by ATM. 2007, Pubmed , Xenbase
Yoo, Mcm2 is a direct substrate of ATM and ATR during DNA damage and DNA replication checkpoint responses. 2004, Pubmed , Xenbase
Yoo, The Mre11-Rad50-Nbs1 complex mediates activation of TopBP1 by ATM. 2009, Pubmed , Xenbase
You, ATM activation and its recruitment to damaged DNA require binding to the C terminus of Nbs1. 2005, Pubmed , Xenbase
Zhong, Rad50 depletion impacts upon ATR-dependent DNA damage responses. 2005, Pubmed
Zou, Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. 2003, Pubmed